Novo Nordisk Says CagriSema Was Tied to 25% Average Weight Loss in Women in a Trial Analysis
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Novo said Tuesday that its experimental weekly injection CagriSema was associated with an average weight loss…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
2 sources behind this story.